Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- Sironax USA, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT04622332
- Locations
- 🇺🇸
Triple O Research Institute, West Palm Beach, Florida, United States
🇺🇸OSF St. Francis Medical Center, Peoria, Illinois, United States
🇺🇸Baptist Medical Center, Jackson, Mississippi, United States
News
No news found